0.3101 USD
+0.05 (+17.91%)
0.2619 USD
-0.05 (-15.54%)
ChartMill assigns a Buy % Consensus number of 80% to ARDS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 3189.26% above the current price.
ARDS was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ARDS.
In the previous month the buy percentage consensus was at a similar level.
ARDS was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-01-26 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-16 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-07-20 | HC Wainwright & Co. | Maintains | Buy |
ARIDIS PHARMACEUTICALS INC / ARDS FAQ
What is the average price target for ARIDIS PHARMACEUTICALS INC (ARDS) stock?
8 analysts have analysed ARDS and the average price target is 10.2 USD. This implies a price increase of 3189.26% is expected in the next year compared to the current price of 0.3101.
What is the consensus rating for ARIDIS PHARMACEUTICALS INC (ARDS) stock?
The consensus rating for ARIDIS PHARMACEUTICALS INC (ARDS) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.